Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval Communication Services Select Sector SPDR Fund XLC Assessing SP 500 Breakout Durability Amid Lagging Market Breadth US Equity Market Resilience Amid Middle East Geopolitical Volatility